El miércoles, la Comisión de Salud Pública del Parlamento adoptó su respuesta al primer plan de salud cardiovascular de la UE. El informe, que responde al “ Plan Corazones Seguros ”, aboga por un enfoque coordinado para la prevención de las enfermedades cardiovasculares (ECV) y sus factores de riesgo y comorbilidades interconectadas, incluidas todas las principales enfermedades […]
Read MoreCommission welcomes political agreement to protect workers from cancer-causing chemicals
The European Commission welcomes the provisional agreement reached by the European Parliament and the Council on the sixth revision of the Carcinogens, Mutagens and Reprotoxic substances Directive (CMRD). Once formally adopted, the strengthened Directive can avert around 1,700 cases of lung cancer and 19,000 work-related illnesses over the next 40 years, while generating up to €1.16 billion in healthcare savings across the […]
Read MoreCommission and EU Drugs Agency present the 2026 European Drug Report
Last June 9, Commissioner for Internal Affairs and Migration, Magnus Brunner and the European Union Drugs Agency (EUDA) are presenting the 2026 European Drug Report 2026, with the latest evidence on the state of the drugs situation in Europe. Based on data from 29 countries (EU-27, Norway and Türkiye), the report shows that drugs have an increasingly negative impact on European health and security as they […]
Read MoreThe EU and the WHO are stepping up their efforts to respond to the Ebola outbreak in the Democratic Republic of the Congo and Uganda
The European Union and the World Health Organisation (WHO) are stepping up their cooperation to support national authorities in responding to the Ebola outbreaks currently occurring in the Democratic Republic of the Congo (DRC) and Uganda, with the aim of rapidly containing transmission, protecting communities and strengthening preparedness in the region, ultimately saving lives. Thanks […]
Read MoreThe European Commission is strengthening global health security through the new Global Health Resilience Initiative
The European Commission has adopted the Global Health Resilience Initiative. This strategy positions the EU as a reliable and leading player in the field of global health, strengthening global prevention, preparedness and response to future health threats and addressing gaps in the resilience of health systems. It sets out the strategic framework for the EU’s […]
Read MoreThe Commission welcomes the political agreement on the Critical Medicines Act
The European Commission welcomes the historic political agreement on the Critical Medicines Act (CMA) reached by the Council and the European Parliament. This agreement marks a significant milestone in strengthening the resilience of the European healthcare sector, preventing medicine shortages and improving the security of supply of essential medicines across the EU. The CMA will […]
Read MoreThe Commission is coordinating the European response to the hantavirus outbreak
The European Commission is taking steps to coordinate and support the responses of national authorities to the hantavirus outbreak. Currently, theEuropean Centre for Disease Prevention and Controlconsiders the risk to the general public in Europeto be very low, given that appropriate infection prevention and control measures are being implemented and that hantaviruses are not easily […]
Read MoreA new law strengthening water protection in the EU comes into force
The EU directiverevising the lists of pollutants in surface water and groundwater came into force today (11 May), ensuring that the lists are brought into line with the latest scientific recommendations and that new substances are subject to more comprehensive monitoring and stricter controls. Three pieces of EU legislation will be amended: theWater Framework Directive, […]
Read MoreThe Commission announces new global health commitments at the ‘One Health’ Summit
The European Commission plans to allocate €700 million to the Global Fund to fight HIV, tuberculosis and malaria. It will also invest €46.5 million to strengthen public health security in Africa and Europe, with a particular focus on combating antimicrobial resistance (AMR), and €50 million in research and development to tackle AMR and neglected tropical […]
Read More








